Early Detection is the Best Protection

About Breast Cancer

Breast cancer is the second leading cause of cancer deaths in women. In the United States alone, there will be an estimated 253,000 new cases of invasive breast cancer and 63,000 new cases of in-situ breast cancer diagnosed in 2017, with 41,000 women dying from the disease.

There is hope. Breast cancer treatment has improved dramatically over the years, increasing survival rates and making breast cancer essentially curable with early detection.

When a woman is diagnosed with early-stage breast cancer, she has many treatment options. A common option is breast-conserving surgery, also known as lumpectomy, followed by radiation treatment. Radiation is used to destroy any potentially remaining cancerous cells after a lumpectomy. This combination of lumpectomy and radiation is proven to increase survival rates in women with early-stage breast cancer. Choosing this treatment combination enables a woman to get back to her life with the peace of mind that she has taken all necessary steps to rid her body of breast cancer.

Concure Oncology offers resources for those wanting to understand this disease, as well as a path for recently diagnosed patients who want to research treatment options, including Breast Microseed Treatment®. Education is perhaps the greatest weapon individuals can arm themselves with in effectively fighting this disease.

The information herein is not designed to replace any conversations a patient has with her healthcare professionals, but simply to assist her in asking the right questions so she can become an active participant in planning her treatment.

Concure Oncology®

Dedicated to helping you put cancer behind you so you can get back to your life faster, with the peace of mind that comes from following the appropriate breast cancer treatment to help prevent a recurrence.

Kevin Kelley
Chief Executive Officer


Learn More 

Contact Us

Concure Oncology
3010 77th Ave. SE, Suite 206
Mercer Island, WA 98040